Concepedia

Yu Ikezono

YI

Statistics

Publications

10

Citations

314

H-Index

10

Active since

2014

Affiliations

Kurume University(Current)

Kurume University Hospital

Osaka Medical and Pharmaceutical University

Tokai University

Japan Hospital Association

Yu Ikezono is an author at Kurume University specializing in medicine, molecular oncology, and oncology.

Publications per year

2014–2019

10

Publications

10

High expression of <scp>CD</scp>44v9 and <scp>xCT</scp> in chemoresistant hepatocellular carcinoma: Potential targets by sulfasalazine

Fumitaka Wada, Hironori Koga, Jun Akiba et al. · Cancer Science · 2018 · 82 citations · Full text

Medicine, Oncology, Pharmacology +16

Glycosylation of ascites-derived exosomal CD133: a potential prognostic biomarker in patients with advanced pancreatic cancer

Takahiko Sakaue, Hironori Koga, Hideki Iwamoto et al. · Medical Molecular Morphology · 2019 · 63 citations · Full text

Medicine, Cell Biology, Oncology +16

Pancreatic Neuroendocrine Tumors and EMT Behavior Are Driven by the CSC Marker DCLK1

Yu Ikezono, Hironori Koga, Jun Akiba et al. · Molecular Cancer Research · 2017 · 39 citations · Full text

Medicine, Cell Biology, Oncology +17

Pigment Epithelium-Derived Factor (PEDF) Prevents Hepatic Fat Storage, Inflammation, and Fibrosis in Dietary Steatohepatitis of Mice

Takafumi Yoshida, Jun Akiba, Takanori Matsui et al. · Digestive Diseases and Sciences · 2017 · 26 citations

Medicine, Nutritional Sciences, Pathology +16

<scp>CD</scp>34<sup>+</sup> cell therapy is safe and effective in slowing the decline of hepatic reserve function in patients with decompensated liver cirrhosis

Tõru Nakamura, Takuji Torimura, Hideki Iwamoto et al. · Journal of Gastroenterology and Hepatology · 2014 · 24 citations

Medicine, Cell Biology, Pathology +17

1–5 of 10